Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
ARE YOU ONE?
Radical Collaboration. Real-World Impact.
Texas expertise fuels the discovery and delivery of next-generation preventions, diagnoses, treatments and cures.
LET'S GO
World Class. Close to Home.
We’re working to make seamless, person-centered care the standard in Central Texas and beyond.
Get Care
More Information
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
ABOUT US
More Information
EXPLORE
Make an Appointment Give Faculty Students Alumni Directory

Kevin Hackshaw, M.D.

Education

MD
Baylor College of Medicine

BS, Chemistry
Brooklyn College

About

<p>Kevin Hackshaw, MD, is a board-certified rheumatologist in UT Medicine’s <a href=”https://utmedicine.org/get-care/browse/clinics/rheumatology”>Rheumatology Clinic</a>. With 30 years of experience, he specializes in fibromyalgia and other conditions that comprise of central sensitivity syndromes, such as rheumatoid arthritis, psoriatic arthritis, gout, systemic lupus erythematosus, vasculitis, and more. Additionally, Dr. Hackshaw is an associate professor and serves as both the interim Associate Chair of Research and the Chief of the Division of Rheumatology for the Dell Medical School Department of Internal Medicine.<br></p>
<p>Dr. Hackshaw earned his bachelor’s degree in chemistry from Brooklyn College and his medical degree from Baylor College of Medicine. He completed both an internship and residency in internal medicine at Harlem Hospital Center/Columbia University College of Physicians and Surgeons as well as a fellowship in rheumatology at the University of Colorado Health.</p>
<p>Dr. Hackshaw’s current and ongoing research investigates potential biomarkers for fibromyalgia and is supported by the National Institutes of Health. His long-term goal involves biomarker characterization that will lend itself towards more specific therapeutic options for conditions where there are currently no definitive blood tests. <br></p>